Why Steroid Dose Alone Cannot Define Steroid-Sparing Value in Asthma Development
Approximately 13 million people worldwide have severe, uncontrolled asthma even with optimized treatment, according to the Global Initiative for Asthma (GINA). In this population, systemic steroid ...
Measuring What Matters: Steroid-toxicity and Patient Outcomes
Ten years ago, two clinical researchers walked into a bar and, over a beer, asked themselves whether the direct measurement of steroid-toxicity would ever be possible. Today, Steritas, in licensing ...
The Trials Driving the Next Wave of Steroid-Sparing Innovation
A wave of clinical trial results using the STOX® Suite of clinical outcome assessments (COAs) in a range of diseases will soon reach the shore, helping to deliver new therapeutic options for ...
Landmark Study Shows Steroids Must Be Tapered Early
Steroids must be tapered early to avoid long-term steroid-toxicities, according to a landmark 3-year observational study of severe asthma patients. The latest data, published in the Journal of ...
Integrating the GTI into Routine Clinical Practice
A recent study published in the journal Rheumatology has investigated the use of the Steritas Glucocorticoid Toxicity Index (GTI) for monitoring steroid-toxicity in clinical practice for individual ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
